Moderna Inc (NAS:MRNA)
$ 132.68 3.58 (2.77%) Market Cap: 50.85 Bil Enterprise Value: 42.17 Bil PE Ratio: 0 PB Ratio: 3.86 GF Score: 68/100

Moderna Inc COVID-19 Variants Announcement Transcript

Jan 25, 2021 / 09:30PM GMT
Release Date Price: $147 (+12.20%)
Operator

Good afternoon, and welcome to Moderna's conference call. (Operator Instructions) Please be advised that the call is being recorded.

At this time, I'd like to turn the call over to Lavina Talukdar, Head, Investor Relations at Moderna. Please proceed.

Lavina Talukdar
Moderna, Inc. - Senior VP & Head of IR

Thank you, operator. Hello, everyone, and welcome to Moderna's conference call to discuss results from in vitro studies against variants of the SARS-CoV-2 virus. You can access the press release issued today as well as the slides that we'll be reviewing by going to the Investors section of our website.

On today's call are Stéphane Bancel, our Chief Executive Officer; Tal Zaks, our Chief Medical Officer; Stephen Hoge, our President; and David Meline, our Chief Financial Officer.

Before we begin, please note that this conference call will include forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Please see Slide 2 of the accompanying presentation and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot